Guardant Health GH
$145.83 +$0.24 (+0.16%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $145.83 0.00%
Open$143.10
Prev close$145.59
Day range$141.01 – $148.27
Volume2.76M
Market cap$19.73B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts19
Average target$202.75+39.0% vs. price
- Buy 100%
Low $180.00Now $145.83Avg $202.75High $225.00
Recent rating changes
The last 20 actions on file set price targets from $180.00 to $220.00, averaging $202.05.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 18 Nov 2026 | Bernstein | BUY | $190.00 |
| 10 Nov 2026 | Piper Sandler | BUY | $190.00 |
| 6 Nov 2026 | TD Cowen | BUY | $220.00 |
| 6 Nov 2026 | CCORF | BUY | $205.00 |
| 6 Nov 2026 | Piper Sandler | BUY | $193.00 |
| 6 Nov 2026 | BofA Securities | BUY | – |
| 6 Nov 2026 | Baird | BUY | $196.00 |
| 6 Nov 2026 | Stifel | BUY | $180.00 |
| 6 Nov 2026 | Goldman Sachs | BUY | $210.00 |
| 6 Nov 2026 | Barclays | BUY | $220.00 |
| 6 Nov 2026 | RBC Capital | BUY | $200.00 |
| 27 Oct 2026 | BTIG | BUY | $210.00 |
| 22 Oct 2026 | Roth MKM | BUY | $200.00 |
| 20 Oct 2026 | Morgan Stanley | BUY | $200.00 |
| 19 Oct 2026 | Bernstein | BUY | $210.00 |
| 16 Oct 2026 | Bernstein | BUY | $210.00 |
| 14 Oct 2026 | J.P. Morgan | BUY | $195.00 |
| 13 Oct 2026 | Morgan Stanley | BUY | $200.00 |
| 12 Oct 2026 | Bernstein | BUY | $210.00 |
| 12 Oct 2026 | Morgan Stanley | BUY | $200.00 |
No comments yet — be the first to weigh in on GH.
Sign in to join the discussion.